Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study
Abstract
OBJECTIVES : To examine the rate and predictors of nursing home placement in patients with Parkinson's disease. DESIGN : Four‐year prospective study. SETTING : A population‐based study in western Norway PARTICIPANTS : 178 community‐dwelling subjects with Parkinson's disease. MEASUREMENTS : Main outcome measure was the time from baseline to nursing home admission. Baseline evaluation of motor symptoms (Unified Parkinson's Disease Rating Scale, UPDRS), cognition (clinical dementia interview, Gottfries, Bråne & Steen dementia scale, and Mini‐Mental State Examination), depression (clinical interview and the Montgomery & Åsberg Depression Rating Scale), and psychotic symptoms (UPDRS Thought Disorder item) were performed. RESULTS : Forty‐seven patients (26.4%) were admitted to a nursing home during the 4‐year study period. Institutionalized patients were older, had more advanced Parkinson's disease with more severe motor symptoms and impairment of activities of daily living, were cognitively more impaired, were more often living alone, and had more hallucinations than those who continued to live at home. Duration of disease, levodopa dose, and gender distribution did not differ between the two groups. A Cox proportional hazards linear regression analysis showed that old age, functional impairment, dementia, and hallucinations were independent predictors of nursing home admission. CONCLUSIONS : Both motor and neuropsychiatric symptoms contributed to institutionalization, but the presence of hallucinations was the strongest predictor. This finding indicates it is possible that effective treatment of hallucinations may reduce the need for institutionalization in patients with Parkinson's disease. J Am Geriatr Soc 48:938–942, 2000 .
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Parkinson disease is progressive, and dementia and medication-refractory motor problems are common reasons for late-stage nursing-home placement.
“Parkinson disease (PD) is progressive, with dementia and medication-refractory motor problems common reasons for late-stage nursing-home placement.”
From Does vigorous exercise have a neuroprotective effect in Parkinson disease? (2011) · cites this paper as [1]
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · see citing works
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107 · see citing works
Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
The Parkinson Study Group (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401003 · Cited by 616 · see citing works
Mental symptoms in Parkinson's disease are important contributors to caregiver distress
Aarsland, D., Larsen, J. P., Karlsen, K., Lim, N. G., & Tandberg, E. (1999) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199910)14:10 · Cited by 484 · see citing works
Self-citationRisk factors for nursing home placement in advanced Parkinson's disease
Goetz, C. G., & Stebbins, G. T. (1993) · Neurology · doi:10.1212/wnl.43.11.2227 · Cited by 460 · see citing works
A prospective study of long-term care institutionalization among the aged.
Branch, L. G., & Jette, A. M. (1982) · American Journal of Public Health · doi:10.2105/ajph.72.12.1373 · Cited by 440 · see citing works
The Occurrence of Depression in Parkinson's Disease
Tandberg, E. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550020087019 · Cited by 413 · see citing works
Self-citationPredictors of Institutionalization Among Caregivers of Patients With Alzheimer's Disease
Colerick, E. J., & George, L. K. (1986) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1986.tb04239.x · Cited by 393 · see citing works
Prevalence and Clinical Correlates of Psychotic Symptoms in Parkinson Disease
Aarsland, D., Larsen, J. P., Cummings, J. L., & Laake, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.595 · Cited by 347 · see citing works
Self-citationA new rating scale for dementia syndromes
Gottfries, C. G., Bråne, G., Gullberg, B., & Steen, G. O. (1982) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(82)90031-0 · Cited by 279 · see citing works
Frequency of Dementia in Parkinson Disease
Aarsland, D., Tandberg, E., Larsen, J. O., & Cummings, J. L. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550060082020 · Cited by 276 · see citing works
Self-citationRisk Factors for Nursing Home Admissions and Exits: A Discrete-time Hazard Function Approach
Greene, V. L., & Ondrich, J. I. (1990) · Journal of Gerontology · doi:10.1093/geronj/45.6.s250 · Cited by 239 · see citing works
The epidemiology of Parkinson's disease in the county of Rogaland, Norway
Tandberg, E., Larsen, J. O., Nessler, E. G., Riise, T., & Aarli, J. A. (1995) · Movement Disorders · doi:10.1002/mds.870100503 · Cited by 177 · see citing works
Self-citationLarsen, J. O., Dupont, E., & Tandberg, E. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1994.tb01674.x · Cited by 176 · see citing works
Self-citationO’Reilly, F., Finnan, F., Allwright, S., Smith, G. D., & Ben‐Shlomo, Y. (1996) · Europe PMC (PubMed Central) · Cited by 130 · see citing works
Mitchell, S. L., Kiely, D. K., Kiel, D. P., & Lipsitz, L. A. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb06408.x · Cited by 78 · see citing works
Olanzapine for Psychosis in Patients With Parkinson's Disease With and Without Dementia
Aarsland, D., Larsen, J. O., Lim, N. G., & Tandberg, E. (1999) · Journal of Neuropsychiatry · doi:10.1176/jnp.11.3.392 · Cited by 77 · see citing works
Self-citationBehavioral Neurology of Movement Disorders
Kurlan, R. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550030021011 · Cited by 67 · see citing works
Larsen, J. O. (1991) · BMJ · doi:10.1136/bmj.303.6805.741 · Cited by 50 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027 · see citing works
Self-citationNon-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807 · see citing works
A systematic review of prevalence studies of dementia in Parkinson's disease
Aarsland, D., ZACCAI, J. H., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,689 · see citing works
Self-citationBalestrino, R., & Schapira, A. H. V. (2020) · European Journal of Neurology · doi:10.1111/ene.14108 · Cited by 1,508 · see citing works
Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22643 · Cited by 1,445 · see citing works
Parkinson disease-associated cognitive impairment
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C. G., Chaudhuri, К. R., & Weintraub, D. A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00280-3 · Cited by 1,442 · see citing works
Self-citationPrevalence and Characteristics of Dementia in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. O., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,403 · see citing works
Self-citationChaudhuri, K. R., Martinez‐Martin, P., Schapira, A. H. V., Stocchi, F., Sethi, K., Odin, P., Brown, R. G., Koller, W., Barone, P., MacPhee, G., et al. (2006) · Movement Disorders · doi:10.1002/mds.20844 · Cited by 1,100 · see citing works
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Williams‐Gray, C. H., Evans, J., Goris, A., Foltynie, T., Ban, M., Robbins, T. W., Brayne, C., Kolachana, B. S., Weinberger, D. R., Sawcer, S. J., et al. (2009) · Brain · doi:10.1093/brain/awp245 · Cited by 970 · see citing works
Dalrymple‐Alford, J. C., MacAskill, M. R., Nakas, C. T., Livingston, L., Graham, C., Crucian, G. P., Melzer, T. R., Kirwan, J. P., Keenan, R., Wells, S. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fc29c9 · Cited by 936 · see citing works
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
Williams‐Gray, C. H., Foltynie, T., Brayne, C., Robbins, T. W., & Barker, R. (2007) · Brain · doi:10.1093/brain/awm111 · Cited by 935 · see citing works
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70212-x · Cited by 883 · see citing works
MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI
Litvan, I., Aarsland, D., Adler, C. H., Goldman, J. G., Kulisevsky, J., Mollenhauer, B., Rodríguez‐Oroz, M., Tröster, A. I., & Weintraub, D. A. (2011) · Movement Disorders · doi:10.1002/mds.23823 · Cited by 811 · see citing works
Self-citationRisk of dementia in Parkinson’s disease
Aarsland, D., Andersen, K., Larsen, J. O., Lolk, A., Nielsen, H., & Kragh-Sørensen, P. (2001) · Neurology · doi:10.1212/wnl.56.6.730 · Cited by 705 · see citing works
Self-citationSubtypes of mild cognitive impairment in parkinson's disease: Progression to dementia
Janvin, C. C., Larsen, J. P., Aarsland, D., & Hugdahl, K. (2006) · Movement Disorders · doi:10.1002/mds.20974 · Cited by 592 · see citing works
Self-citationNeuropsychiatric symptoms in Parkinson's disease
Aarsland, D., Marsh, L., & Schrag, A. (2009) · Movement Disorders · doi:10.1002/mds.22589 · Cited by 320 · see citing works
Self-citationMartínez‐Martín, P., Schapira, A. H. V., Stocchi, F., Sethi, K. D., Odin, P., Macphee, G. J. A., Brown, R. G., Naidu, Y., Clayton, L. M. S., Abe, K., et al. (2007) · Movement Disorders · doi:10.1002/mds.21586 · Cited by 556 · see citing works
Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group
Ravina, B., Marder, K., Fernandez, H. H., Friedman, J. H., McDonald, W., Murphy, D., Aarsland, D., Babcock, D., Cummings, J., Endicott, J., et al. (2007) · Movement Disorders · doi:10.1002/mds.21382 · Cited by 528 · see citing works
Self-citationAarsland, D., Brønnick, K., Ehrt, U., Deyn, P. P. D., Tekin, S., Emre, M., & Cummings, J. L. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.083113 · Cited by 519 · see citing works
Self-citationDoes vigorous exercise have a neuroprotective effect in Parkinson disease?
Ahlskog, J. E. (2011) · Neurology · doi:10.1212/wnl.0b013e318225ab66 · Cited by 463 · see citing works
Changes in motor subtype and risk for incident dementia in Parkinson's disease
Alves, G. W., Larsen, J. P., Emre, M., Wentzel‐Larsen, T., & Aarsland, D. (2006) · Movement Disorders · doi:10.1002/mds.20897 · Cited by 434 · see citing works
Self-citationParkinson’s disease dementia: a neural networks perspective
Gratwicke, J., Jahanshahi, M., & Foltynie, T. (2015) · Brain · doi:10.1093/brain/awv104 · Cited by 436 · see citing works
The retina in Parkinson's disease
Archibald, N. K., Clarke, M. W., Mosimann, U. P., & Burn, D. J. (2009) · Brain · doi:10.1093/brain/awp068 · Cited by 408 · see citing works
A 12-Year Population-Based Study of Psychosis in Parkinson Disease
Forsaa, E. B., Larsen, J. P., Wentzel‐Larsen, T., Goetz, C. G., Stebbins, G. T., Aarsland, D., & Alves, G. W. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.166 · Cited by 400 · see citing works
Self-citationHealth‐related quality of life in early Parkinson's disease: The impact of nonmotor symptoms
Duncan, G. W., Khoo, T. K., Yarnall, A. J., O'Brien, J. T., Coleman, S. Y., Brooks, D. J., Barker, R. A., & Burn, D. J. (2013) · Movement Disorders · doi:10.1002/mds.25664 · Cited by 383 · see citing works
Epidemiology of Parkinson’s disease
Alves, G. W., Forsaa, E. B., Pedersen, K. F., Gjerstad, M. D., & Larsen, J. P. (2008) · Journal of Neurology · doi:10.1007/s00415-008-5004-3 · Cited by 378 · see citing works
Self-citationA pathophysiological model of freezing of gait in Parkinson's disease
Lewis, S. J. G., & Barker, R. A. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.08.006 · Cited by 343 · see citing works
Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study
Aarsland, D. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.708 · Cited by 341 · see citing works
Self-citationParkinson's disease is associated with hippocampal atrophy
Camicioli, R. M., Moore, M. M., Kinney, A. E. “., Corbridge, E., Glassberg, K., & Kaye, J. A. (2003) · Movement Disorders · doi:10.1002/mds.10444 · Cited by 330 · see citing works
Marsh, L., McDonald, W. M., Cummings, J. L., Ravina, B. M., & NINDS/NIMH Work Group on Depression and Parkinson's Disease (2005) · Movement Disorders · doi:10.1002/mds.20723 · Cited by 319 · see citing works
Hallucinations in Parkinson disease
Diederich, N. J., Fénelon, G., Stebbins, G., & Goetz, C. G. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.62 · Cited by 312 · see citing works
Burn, D. J., Emre, M., McKeith, I. G., Deyn, P. P. D., Aarsland, D., Hsu, C., & Lane, R. M. (2006) · Movement Disorders · doi:10.1002/mds.21077 · Cited by 310 · see citing works
Self-citationVisual dysfunction in Parkinson disease without dementia
Uc, E. Y., Rizzo, M., Anderson, S. W., Qian, S., Rodnitzky, R. L., & Dawson, J. D. (2005) · Neurology · doi:10.1212/01.wnl.0000191565.11065.11 · Cited by 308 · see citing works
The impact of depressive symptoms in early Parkinson disease
Ravina, B. M., Camicioli, R. M., Como, P. G., Marsh, L., Jankovic, J. J., Weintraub, D. A., & Elm, J. J. (2007) · Neurology · doi:10.1212/01.wnl.0000268695.63392.10 · Cited by 301 · see citing works
Diederich, N. J., Goetz, C. G., & Stebbins, G. T. (2004) · Movement Disorders · doi:10.1002/mds.20308 · Cited by 290 · see citing works
The Rate of Cognitive Decline in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. P., Perry, R., Wentzel‐Larsen, T., Lolk, A., & Kragh-Sørensen, P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1906 · Cited by 282 · see citing works
Self-citationEpidemiology of psychosis in Parkinson's disease
Fénelon, G., & Alves, G. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.014 · Cited by 330 · see citing works
Weintraub, D. A., Oehlberg, K. A., Katz, I. R., & Stern, M. B. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000192488.66049.4b · Cited by 279 · see citing works
Cognitive dysfunction and dementia in Parkinson?s disease
Bosboom, J. L. W., Stoffers, D., & Wolters, E. C. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0168-1 · Cited by 274 · see citing works
Clinical phenotype of Parkinson disease dementia
Galvin, J. E., Pollack, J., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000242630.52203.8f · Cited by 264 · see citing works
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
Weintraub, D., Mavandadi, S., Mamikonyan, E., Siderowf, A. D., Duda, J. E., Hurtig, H. I., Colcher, A., Horn, S. S., Nazem, S., Ten Have, T. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ebdd79 · Cited by 255 · see citing works
Rabey, J. M., Prokhorov, T., Miniovitz, A., Dobronevsky, E., & Klein, C. (2006) · Movement Disorders · doi:10.1002/mds.21116 · Cited by 259 · see citing works
Coelho, M. M., & Ferreira, J. J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.126 · Cited by 250 · see citing works
The non-motor symptom complex of Parkinson’s disease: A comprehensive assessment is essential
Chaudhuri, К. R., Yates, L. R., & Martínez‐Martín, P. (2005) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-005-0072-6 · Cited by 244 · see citing works
Cognitive dysfunction and dementia in Parkinson disease
Caballol, N. S., Martı́, M. J., & TOLOSA, E. S. (2007) · Movement Disorders · doi:10.1002/mds.21677 · Cited by 242 · see citing works
The clinical heterogeneity of Parkinson's disease and its therapeutic implications
Greenland, J. C., Williams‐Gray, C. H., & Barker, R. A. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14094 · Cited by 239 · see citing works
Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis
Goetz, C. G., Emre, M., & Dubois, B. (2009) · Annals of Neurology · doi:10.1002/ana.21455 · Cited by 232 · see citing works
Stahl, S. M. (2016) · CNS Spectrums · doi:10.1017/s1092852916000407 · Cited by 221 · see citing works
Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia
Aarsland, D., Hutchinson, M., & Larsen, J. P. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.949 · Cited by 219 · see citing works
Self-citationTherapies in Parkinsonʼs disease
Jankovic, J. J., & Poewe, W. H. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283542fc2 · Cited by 213 · see citing works
Pathophysiology and Treatment of Psychosis in Parkinson’s Disease
Zahodne, L. B., & Fernandez, H. H. (2008) · Drugs & Aging · doi:10.2165/00002512-200825080-00004 · Cited by 211 · see citing works
Combined effect of age and severity on the risk of dementia in Parkinson's disease
Levy, G., Schupf, N., Tang, M., COTE, L. J., Louis, E. D., Mejia‐Santana, H., Stern, Y., & Marder, K. S. (2002) · Annals of Neurology · doi:10.1002/ana.10219 · Cited by 209 · see citing works
GBA Variants are associated with a distinct pattern of cognitive deficits in P arkinson's disease
Mata, I. F., Leverenz, J. B., Weintraub, D. A., Trojanowski, J. Q., Chen‐Plotkin, A. S., Deerlin, V. M. V., Ritz, B. R., Rausch, R., Factor, S. A., Wood‐Siverio, C., et al. (2015) · Movement Disorders · doi:10.1002/mds.26359 · Cited by 203 · see citing works
Visual symptoms in Parkinson's disease and Parkinson's disease dementia
Archibald, N. K., Clarke, M. P., Mosimann, U. P., & Burn, D. J. (2011) · Movement Disorders · doi:10.1002/mds.23891 · Cited by 207 · see citing works
APOE,MAPT, andSNCAGenes and Cognitive Performance in Parkinson Disease
Mata, I. F., Leverenz, J. B., Weintraub, D. A., Trojanowski, J. Q., Hurtig, H. I., Deerlin, V. M. V., Ritz, B. R., Rausch, R., Rhodes, S. L., Factor, S. A., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1455 · Cited by 203 · see citing works
Neuropsychiatric Symptoms of Patients With Progressive Supranuclear Palsy and Parkinson's Disease
Aarsland, D., Litvan, I., & Larsen, J. O. (2001) · Journal of Neuropsychiatry · doi:10.1176/jnp.13.1.42 · Cited by 205 · see citing works
Self-citationPsychiatric aspects of Parkinson?s disease: An Update
Schrag, A. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0483-3 · Cited by 200 · see citing works
Greenberg, S. A. (2007) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000292204.52313.f3 · Cited by 196 · see citing works
Amboni, M., Tessitore, A., Esposito, F., Santangelo, G., Picillo, M., Vitale, C., Giordano, A., Erro, R., Micco, R. D., Corbo, D., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7591-5 · Cited by 192 · see citing works
Scales to assess psychosis in Parkinson's disease: Critique and recommendations
Fernandez, H. H., Aarsland, D., Fénelon, G., Friedman, J. H., Marsh, L., Tröster, A. I., Poewe, W. H., Rascol, O., Sampaio, C., Stebbins, G. T., et al. (2008) · Movement Disorders · doi:10.1002/mds.21875 · Cited by 188 · see citing works
Self-citationProdromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease
Woods, S. P., & Tröster, A. I. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703910022 · Cited by 188 · see citing works
Progression of motor symptoms in Parkinson’s disease
Xia, R., & Mao, Z. (2012) · Neuroscience Bulletin · doi:10.1007/s12264-012-1050-z · Cited by 186 · see citing works
Compta, Y., Martı́, M. J., Ibarretxe‐Bilbao, N., Junqué, C., Valldeoriola, F., Muñoz, E., Ezquerra, M., Ríos, J., & TOLOSA, E. S. (2009) · Movement Disorders · doi:10.1002/mds.22594 · Cited by 185 · see citing works
Profile of Cognitive Impairment in Parkinson's Disease
Watson, G. S., & Leverenz, J. B. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00373.x · Cited by 186 · see citing works
Dorsey, E. R., Deuel, L. M., Voss, T., Finnigan, K. S., George, B. P., Eason, S., Miller, D. W., Reminick, J. I., Appler, A., Polanowicz, J., et al. (2010) · Movement Disorders · doi:10.1002/mds.23145 · Cited by 184 · see citing works
Janvin, C. C., Aarsland, D., & Larsen, J. P. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988705277540 · Cited by 182 · see citing works
Self-citationLate-Life Psychosis: Diagnosis and Treatment
Reinhardt, M. M., & Cohen, C. I. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-014-0542-0 · Cited by 182 · see citing works
Williams‐Gray, C. H., Hampshire, A., Robbins, T. W., Owen, A. M., & Barker, R. A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0774-07.2007 · Cited by 180 · see citing works
Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease
Narayanan, N. S., Rodnitzky, R. L., & Uc, E. Y. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0004 · Cited by 176 · see citing works
Levodopa unresponsive symptoms in Parkinson disease
Sethi, K. D. (2008) · Movement Disorders · doi:10.1002/mds.22049 · Cited by 177 · see citing works
Hermanowicz, S., & Hermanowicz, N. S. (2016) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1158102 · Cited by 173 · see citing works
Meireles, J., & Massano, J. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00088 · Cited by 172 · see citing works
Emergency hospital admissions in idiopathic Parkinson's disease
Woodford, H. J., & Walker, R. W. (2005) · Movement Disorders · doi:10.1002/mds.20485 · Cited by 170 · see citing works
Dorsey, E. R., George, B. P., Leff, B. A., & Willis, A. W. (2013) · Neurology · doi:10.1212/wnl.0b013e318293e2ce · Cited by 168 · see citing works
The challenge of non-motor symptoms in Parkinson’s disease
Chaudhuri, К. R., & Odin, P. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84017-8 · Cited by 164 · see citing works
Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease
Prats, A., Saleta, H. G., Crespo, M. C., Silvestre, E., Garolera, M., Torrellas, C. P., Pont, S. A., Nadal, M. F., Garcia, S. A., Bartolomé, M. V. P., et al. (2011) · Movement Disorders · doi:10.1002/mds.23688 · Cited by 162 · see citing works
The Neuropsychiatry of Parkinson Disease: A Perfect Storm
Weintraub, D. A., & Mamikonyan, E. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.03.002 · Cited by 164 · see citing works
The effect of age of onset of PD on risk of dementia
Aarsland, D., Kvaløy, J. T., Andersen, K., Larsen, J. P., Tang, M. X., Lolk, A., Kragh-Sørensen, P., & Marder, K. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0234-8 · Cited by 162 · see citing works
Self-citationThe Malignant Course of “Benign Hallucinations” in Parkinson Disease
Goetz, C. G., Fan, W., Leurgans, S. E., Bernard, B. A., & Stebbins, G. T. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.713 · Cited by 161 · see citing works
How common are complications of Parkinson's disease?
Schrag, A. E., Ben‐Shlomo, Y., & Quinn, N. P. (2002) · Journal of Neurology · doi:10.1007/s004150200032 · Cited by 156 · see citing works
Rater-blinded, Prospective Comparison
Merims, D., Balas, M., Peretz, C., Shabtai, H., & Giladi, N. (2006) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000236769.31279.19 · Cited by 156 · see citing works
Mild cognitive impairment in Parkinson's disease.
Goldman, J. G., & Litvan, I. (2011) · PubMed · Cited by 152 · see citing works
Goldman, J. G., Stebbins, G. T., Dinh, V., Bernard, B. A., Merkitch, D., deToledo‐Morrell, L., & Goetz, C. G. (2014) · Brain · doi:10.1093/brain/awt360 · Cited by 152 · see citing works
Psychiatric Complications in Parkinson Disease
Weintraub, D. A., & Stern, M. B. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.10.844 · Cited by 147 · see citing works
Cognitive impairment in Parkinson's disease and dementia with Lewy bodies
Aarsland, D. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.09.034 · Cited by 145 · see citing works
Self-citationPredictors of nursing home placement in Huntington disease
Wheelock, V., Tempkin, T., Marder, K. S., NANCE, M. A., Myers, R. H., Zhao, H., Kayson, E., Orme, C., Shoulson, I., & the Huntington Study Group (2003) · Neurology · doi:10.1212/01.wnl.0000052992.58107.67 · Cited by 145 · see citing works
The economic impact of cognitive impairment in Parkinson's disease
Vossius, C., Larsen, J. O., Janvin, C. C., & Aarsland, D. (2011) · Movement Disorders · doi:10.1002/mds.23661 · Cited by 142 · see citing works
Self-citationDementia Risk in Parkinson Disease
Setó‐Salvia, N., Clarimón, J., Pagonabarraga, J., Pascual‐Sedano, B., Campolongo, A., Combarros, O., Mateo, J. I., Regaña, D., Martínez-Corral, M., Marquié, M., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.17 · Cited by 142 · see citing works
Trial of pimavanserin in dementia-related psychosis
Tariot, P. N., Cummings, J. L., Soto-Martin, M. E., Ballard, C., Erten-Lyons, D., Sultzer, D. L., Devanand, D. P., Weintraub, D., McEvoy, B., Youakim, J. M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034634 · Cited by 145 · see citing works
The spectrum of cognitive impairment in Lewy body diseases
Goldman, J. G., Williams‐Gray, C. H., Barker, R. A., Duda, J. E., & Galvin, J. E. (2014) · Movement Disorders · doi:10.1002/mds.25866 · Cited by 142 · see citing works
Bilateral Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson Disease Dementia
Gratwicke, J., Zrinzo, L. U., Kahan, J., Peters, A., Beigi, M., Akram, H., Hyam, J. A., Oswal, A., Day, B. L., Mancini, L., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3762 · Cited by 141 · see citing works
A randomized controlled trial of quetiapine for psychosis in Parkinson’s disease
Shotbolt, P. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s5335 · Cited by 140 · see citing works
Frucht, S. J. (2004) · The Neurologist · doi:10.1097/01.nrl.0000131146.08278.a5 · Cited by 139 · see citing works
Silveira, C. R. A., MacKinley, J. D., Coleman, K. K. L., Li, Z., Finger, E. C., Bartha, R., Morrow, S. A., Wells, J., BORRIE, M. J., Tirona, R. G., et al. (2019) · BMC Neurology · doi:10.1186/s12883-019-1252-3 · Cited by 138 · see citing works
Friedman, J. H., Berman, R., Goetz, C. G., Factor, S. A., Ondo, W. G., Wojcieszek, J., Carson, W. H., & Marcus, R. N. (2006) · Movement Disorders · doi:10.1002/mds.21091 · Cited by 138 · see citing works
Predictors of weight loss in Parkinson's disease
Uc, E. Y., Struck, L. K., Rodnitzky, R. L., Zimmerman, B. M., Dobson, J., & Evans, W. J. (2006) · Movement Disorders · doi:10.1002/mds.20837 · Cited by 137 · see citing works
The Treatment of Sleep Disorders in Parkinson’s Disease: From Research to Clinical Practice
Loddo, G., Buonaura, G. C., Sambati, L., Giannini, G., Cecere, A., Cortelli, P., & Provini, F. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00042 · Cited by 135 · see citing works
A semi‐structured interview to assess visual hallucinations in older people
Mosimann, U. P., Collerton, D., Dudley, R. E. J., Meyer, T. D., Graham, G., Dean, J. L., Bearn, D., Killen, A., Dickinson, L., Clarke, M. P., et al. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1965 · Cited by 135 · see citing works
Excessive Daytime Sleepiness in Patients with Parkinsonʼs Disease
Knie, B., Mitra, M. T., Logishetty, K., & Chaudhuri, K. R. (2011) · CNS Drugs · doi:10.2165/11539720-000000000-00000 · Cited by 132 · see citing works
Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s disease
Orgeta, V., McDonald, K. R., Poliakoff, E., Hindle, J. V., Clare, L., & Leroi, I. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011961.pub2 · Cited by 130 · see citing works
- Authors
- Aarsland, D., Larsen, J. P., Tandberg, E., & Laake, K.
- Affiliations
- Stavanger University Hospital (NO)
- Oslo University Hospital (NO)
- Corresponding author
- Aarsland, Dag
- ORCID
- Aarsland, Dag
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2000-08
- Volume
- 48
- Issue
- 8
- Pages
- 938-942
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W2083220625
- Cited by
- 811
- References
- 21
- Citations by year
- 2026: 15 · 2025: 30 · 2024: 30 · 2023: 33 · 2022: 33 · 2021: 42 · 2020: 64 · 2019: 36 · 2018: 35 · 2017: 36 · 2016: 37 · 2015: 32 · 2014: 42 · 2013: 42 · 2012: 33
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Geriatrics Society (publishedVersion)
- PubMed (publishedVersion)
- Journal of the American Geriatrics Society
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Health Professions › General Health Professions › Geriatric Care and Nursing Homes
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Parkinson's disease, nursing home admission, institutionalization, predictors of institutionalization, hallucinations, dementia, functional disability, activities of daily living, motor symptoms, neuropsychiatric symptoms, depression, community-dwelling patients
- MeSH terms
- Activities of Daily Living, Adult, Aged, Aged, 80 and over, Dementia, Female, Hallucinations, Humans, Male, Middle Aged, Norway, Nursing Homes, Parkinson Disease, Patient Admission, Predictive Value of Tests, Prospective Studies, Psychiatric Status Rating Scales, Risk Factors, Severity of Illness Index, Geriatric Assessment, Linear Models, Proportional Hazards Models, Age Distribution, Community Health Planning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
